Noble Capital Markets research on Helius Medical Technologies is published under ticker symbols HSDT and HSM:CA. The price target is in USD and based on ticker symbol HSDT.
Helius Medical Technologies Inc is a medical technology company. It is focused on the development of products for the treatment of neurological symptoms caused by disease or trauma. The company has developed its first, known as the portable neuromodulation stimulator or PoNS, device, is designed to enhance the brain’s ability to compensate for this damage.